News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Topper James N
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 01/10/2023 |
4
| Topper James N (10% Owner) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Granted 10,600 options to buy
@ $23.23, valued at
$246.2k
Granted 3,900 restricted stock units
@ $0 |
|
| 01/05/2023 |
4
| Topper James N (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 09/26/2022 |
4
| Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $10.02, valued at
$200.4k
|
|
| 08/09/2022 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Bought 250,000 shares
@ $20, valued at
$5M
|
|
| 05/03/2022 |
4
| Frazier Life Sciences X, L.P. (10% Owner) has filed a Form 4 on HilleVax, Inc.|
Txns:
| Converted 2,736,234 shares
@ $13.6, valued at
$37.2M
Bought 1,764,706 shares
@ $17, valued at
$30M
Converted 37,212,796 convertible notes
@ $13.6, valued at
$506.1M
|
|
| 04/28/2022 |
3
| Frazier Life Sciences X, L.P. (10% Owner) has filed a Form 3 on HilleVax, Inc. |
| 02/15/2022 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Bought 112,665 shares
@ $7.1006, valued at
$800k
|
|
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Topper James N (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 09/21/2021 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Disposed/sold 1,200,000 shares
@ $0
Granted 1,200,000 warrants
@ $0.001, valued at
$1.2k
|
|
| 05/12/2021 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Disposed of 2,108,558 shares
@ $0
Acquired 96,574 shares
@ $0
Disposed of 96,574 shares
@ $0 |
|
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
3/A
| Topper James N (CEO) has filed a Form 3/A on Frazier Lifesciences Acquisition Corp |
| 12/11/2020 |
4
| Topper James N (CEO) has filed a Form 4 on Frazier Lifesciences Acquisition Corp|
Txns:
| Granted 501,000 shares
@ $10, valued at
$5M
Bought 1,000,000 shares
@ $10, valued at
$10M
Granted 167,000 warrants
@ $11.5, valued at
$1.9M
Granted 333,333 warrants
@ $11.5, valued at
$3.8M
|
|
| 12/08/2020 |
3
| Topper James N (CEO) has filed a Form 3 on Frazier Lifesciences Acquisition Corp |
| 11/18/2020 |
4
| Topper James N (Director) has filed a Form 4 on ANAPTYSBIO, INC|
Txns:
| Disposed of 973,612 shares
@ $0
Disposed of 344,860 shares
@ $0
Disposed of 98,275 shares
@ $0
Acquired 22,604 shares
@ $0
Acquired 26,354 shares
@ $0 |
|
| 11/18/2020 |
4
| Topper James N (10% Owner) has filed a Form 4 on Allena Pharmaceuticals, Inc.|
Txns:
| Granted 14,000 options to buy
@ $1.45, valued at
$20.3k
|
|
| 10/20/2020 |
4
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 4 on Tarsus Pharmaceuticals, Inc.|
Txns:
| Converted 1,390,376 shares
@ $0
Converted 214,281 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 1,390,376 preferred shares
@ $0
Converted 214,281 preferred shares
@ $0 |
|
| 10/15/2020 |
3
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
| 06/16/2020 |
4
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,456,854 shares
@ $0 |
|
| 05/22/2020 |
4
| Topper James N (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $36.85, valued at
$368.5k
|
|
| 04/02/2020 |
4
| Topper James N (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 4,976 shares
@ $2.16, valued at
$10.7k
|
|
| 03/03/2020 |
4
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 4 on Passage BIO, Inc.|
Txns:
| Converted 2,977,242 shares
@ $0
Converted 1,049,175 shares
@ $0
Converted 432,802 shares
@ $0
Bought 550,000 shares
@ $18, valued at
$9.9M
Converted 2,977,242 preferred shares
@ $0
Converted 1,049,175 preferred shares
@ $0
Converted 432,802 preferred shares
@ $0 |
|
| 02/27/2020 |
3
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 3 on Passage BIO, Inc. |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/06/2020 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Converted 6,360,272 shares
@ $0
Converted 2,099,019 shares
@ $0
Converted 1,074,467 shares
@ $0
Bought 500,000 shares
@ $17, valued at
$8.5M
Converted 6,360,272 preferred shares
@ $0
Converted 2,099,019 preferred shares
@ $0
Converted 1,074,467 preferred shares
@ $0 |
|
| 01/31/2020 |
3/A
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 3/A on Arcutis Biotherapeutics, Inc. |
| 01/13/2020 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Sold 50,000 shares
@ $5.0002, valued at
$250k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2020 |
4
| Topper James N (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 5,018 options to buy
@ $3.42, valued at
$17.2k
|
|
| 10/30/2019 |
4
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Converted 1,353,640 shares
@ $15.2, valued at
$20.6M
Bought 1,052,631 shares
@ $19, valued at
$20M
Converted convertible notes
@ $0 |
|
| 10/24/2019 |
3
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 3 on Phathom Pharmaceuticals, Inc. |
|
|
|